Prospective study of Imetelstat in patients with essential thrombocytopenia (ET)

Trial Profile

Prospective study of Imetelstat in patients with essential thrombocytopenia (ET)

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 10 Nov 2015

At a glance

  • Drugs Imetelstat (Primary)
  • Indications Essential thrombocythaemia
  • Focus Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 10 Nov 2015 New trial record
    • 05 Nov 2015 According to a Geron Corporation media release, results from this study will be presented at the 57th American Society of Hematology Annual meeting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top